Results: 12
Targeted Therapy for Idiopathic Pulmonary Fibrosis: Where To Now?
- Published in:
- Drugs, 2016, v. 76, n. 3, p. 291, doi. 10.1007/s40265-015-0523-6
- By:
- Publication type:
- Article
Prevention and Treatment of Venous Thromboembolism in Patients with Cancer: Focus on Drug Therapy.
- Published in:
- Drugs, 2016, v. 76, n. 3, p. 331, doi. 10.1007/s40265-015-0526-3
- By:
- Publication type:
- Article
Tau Biology and Tau-Directed Therapies for Alzheimer's Disease.
- Published in:
- Drugs, 2016, v. 76, n. 3, p. 301, doi. 10.1007/s40265-015-0529-0
- By:
- Publication type:
- Article
Inhaled Umeclidinium in COPD Patients: A Review and Meta-Analysis.
- Published in:
- Drugs, 2016, v. 76, n. 3, p. 343, doi. 10.1007/s40265-015-0532-5
- By:
- Publication type:
- Article
Elotuzumab: First Global Approval.
- Published in:
- Drugs, 2016, v. 76, n. 3, p. 397, doi. 10.1007/s40265-016-0540-0
- By:
- Publication type:
- Article
Insulin Glargine 300 U/mL: A Review in Diabetes Mellitus.
- Published in:
- Drugs, 2016, v. 76, n. 3, p. 363, doi. 10.1007/s40265-016-0541-z
- By:
- Publication type:
- Article
Pembrolizumab: A Review in Advanced Melanoma.
- Published in:
- Drugs, 2016, v. 76, n. 3, p. 375, doi. 10.1007/s40265-016-0543-x
- By:
- Publication type:
- Article
Sacubitril/Valsartan: A Review in Chronic Heart Failure with Reduced Ejection Fraction.
- Published in:
- Drugs, 2016, v. 76, n. 3, p. 387, doi. 10.1007/s40265-016-0544-9
- By:
- Publication type:
- Article
Erratum to: Cariprazine: First Global Approval.
- Published in:
- Drugs, 2016, v. 76, n. 3, p. 419, doi. 10.1007/s40265-016-0547-6
- By:
- Publication type:
- Article
Ixazomib: First Global Approval.
- Published in:
- Drugs, 2016, v. 76, n. 3, p. 405, doi. 10.1007/s40265-016-0548-5
- By:
- Publication type:
- Article
Selexipag: First Global Approval.
- Published in:
- Drugs, 2016, v. 76, n. 3, p. 413, doi. 10.1007/s40265-016-0549-4
- By:
- Publication type:
- Article
What to Do, and What Not to Do, When Diagnosing and Treating Breakthrough Cancer Pain (BTcP): Expert Opinion.
- Published in:
- Drugs, 2016, v. 76, n. 3, p. 315, doi. 10.1007/s40265-015-0519-2
- By:
- Publication type:
- Article